Pathophysiology, Detection and Prevention of Neurological Adverse Events in Cancer Patients
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: closed (15 September 2023) | Viewed by 2895
Special Issue Editors
Interests: chemotherapy-induced neuropathy; immune related adverse events; neuroprotection; neurotoxicology; neurodegeneration
Interests: post-chemotherapy cognitive impairment; immune effector cell-associated neurotoxicity syndrome; biomarkers; neurotoxicology; neuroprotection
Special Issue Information
Dear Colleagues,
Treatments for malignant diseases have become increasingly diverse over the past decade, as have the neurological side effects of tumor therapies. The neurological adverse events of complex treatment strategies, including cytotoxic substances, radiotherapy, immunotherapy, cell-based therapies, and targeted molecular therapies in mono and combination therapy, are creating an increasingly complex interdisciplinary challenge. As all sections of the nervous system can be damaged, the clinical spectrum is very broad and, still for many conditions, incompletely understood. With this Special Issue, we would like to follow a patient-centered approach in focusing on mechanistic insights and cell biology leading to neurological adverse events, and we invite the submission of preclinical and translational articles that improve our knowledge about underlying pathophysiological processes and biomarkers as well as novel neuroprotective approaches.
Dr. Wolfgang Boehmerle
Dr. Petra Huehnchen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chemotherapy-induced neuropathy
- post-chemotherapy cognitive impairment
- immune related adverse events
- immune effector cell-associated neurotoxicity syndrome
- radiotoxicity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
